Page last updated: 2024-12-05

bromotrichloromethane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bromotrichloromethane: A potent liver poison. In rats, bromotrichloromethane produces about three times the degree of liver microsomal lipid peroxidation as does carbon tetrachloride. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6383
CHEMBL ID160802
SCHEMBL ID109417
MeSH IDM0002953

Synonyms (50)

Synonym
AKOS015833938
75-62-7
wln: gxgge
monobromotrichloromethane
carbon bromotrichloride
bromotrichloromethane
trichlorobromomethane
nsc-8017
nsc8017
methane, bromotrichloro-
einecs 200-886-0
brn 1732543
ccris 2393
hsdb 5208
epa pesticide chemical code 008708
caswell no. 118
carbon trichlorobromide
nsc 8017
trichloromethyl bromide
bromotrichloromethane, 99%
bromo(trichloro)methane
B0662
CHEMBL160802
bromo-trichloro-methane
NCGC00249206-01
tox21_303534
dtxsid7023930 ,
NCGC00257422-01
cas-75-62-7
dtxcid003930
NCGC00259841-01
tox21_202292
4-01-00-00077 (beilstein handbook reference)
ikj30qxm63 ,
unii-ikj30qxm63
FT-0623266
SCHEMBL109417
bromotrichloromethane [hsdb]
bromo trichloromethane
cbrcl3
ccl3br
brccl3
J-519951
BR1357
mfcd00000783
bromotrichloro methane
Q23780617
AS-57509
CS-0031583
E87219

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" TCBM, like CT, reduces the hepatic level of GSH-S-transferase, increasing the amount of DBE available for cytochrome P450-dependent metabolism, with the production of toxic metabolites."( In vivo studies on halogen compound interactions. IV. Interaction among different halogen derivatives with and without synergistic action on liver toxicity.
Aragno, M; Danni, O; Tamagno, E; Ugazio, G, 1992
)
0.28
" CD, known to potentiate hepatotoxic and lethal effects of halomethanes in rats, failed to potentiate the toxic effects of any of these three halomethanes in gerbils."( Hepatotoxicity and lethality of halomethanes in Mongolian gerbils pretreated with chlordecone, phenobarbital or mirex.
Cai, Z; Mehendale, HM, 1991
)
0.28
" These findings suggest that the suppression of stimulated hepatocellular regeneration results in the loss of the essential mechanism of tissue repair leading to continuation of the toxic liver injury associated with the CD + BrCCl3 combination treatment."( Potentiation of BrCCl3 hepatotoxicity by chlordecone: biochemical and ultrastructural study.
Faroon, OM; Henry, RW; Mehendale, HM; Soni, MG, 1991
)
0.28
" Effect of CD on 48 hr LD50 of BrCCl3 was also examined using the method of moving averages."( Potentiation of bromotrichloromethane hepatotoxicity and lethality by chlordecone preexposure in the rat.
Agarwal, AK; Mehendale, HM,
)
0.48

Dosage Studied

ExcerptRelevanceReference
"These studies were designed to provide dose-response relationships for chlordecone (CD) potentiation of BrCCl3 hepatotoxicity in male rats using biochemical, functional and histopathological parameters."( Potentiation of bromotrichloromethane hepatotoxicity and lethality by chlordecone preexposure in the rat.
Agarwal, AK; Mehendale, HM,
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency0.03650.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency5.79160.000221.22318,912.5098AID1259243
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency35.31130.003041.611522,387.1992AID1159552; AID1159555
aryl hydrocarbon receptorHomo sapiens (human)Potency76.02060.000723.06741,258.9301AID743085
heat shock protein beta-1Homo sapiens (human)Potency60.89890.042027.378961.6448AID743210
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID37562Induction of aneuploidy in Aspergillus nidulans.1995Journal of medicinal chemistry, Feb-17, Volume: 38, Issue:4
Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications.
AID19825Partition coefficient (logP)1995Journal of medicinal chemistry, Feb-17, Volume: 38, Issue:4
Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (91)

TimeframeStudies, This Drug (%)All Drugs %
pre-199048 (52.75)18.7374
1990's39 (42.86)18.2507
2000's4 (4.40)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.23 (24.57)
Research Supply Index4.55 (2.92)
Research Growth Index4.11 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (3.19%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other91 (96.81%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]